Chronic treatment with scopolamine and physostigmine changes nerve growth factor (NGF) receptor density and NGF content in rat brain
Open Access
- 1 March 1991
- journal article
- Published by Elsevier in Brain Research
- Vol. 542 (2) , 233-240
- https://doi.org/10.1016/0006-8993(91)91572-i
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Limbic Seizures Increase Neuronal Production of Messenger RNA for Nerve Growth FactorScience, 1989
- Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: Response to fimbria‐fornix transectionJournal of Comparative Neurology, 1989
- Differential expression of the nerve growth factor receptor gene in multiple brain areasDevelopmental Brain Research, 1988
- Expression of the β-Nerve Growth Factor Gene in Hippocampal NeuronsScience, 1988
- POTENTIAL PHARMACOTHERAPY OF ALZHEIMER DISEASE. A COMPARISON OF VARIOUS FORMS OF PHYSOSTIGMINE ADMINISTRATIONActa Neurologica Scandinavica, 1988
- NGF receptor immunoreactivity in rat brain: Topographic distribution and response to entorhinal ablationNeuroscience Letters, 1987
- Beta-adrenergic receptor regulation of NGF-mRNA content in rat C6-2b glioma cellsNeuropharmacology, 1987
- Nerve growth factor and Alzheimer's diseaseAnnals of Neurology, 1986
- Scopolamine induces an increase in muscarinic receptor level in rat hippocampusBrain Research, 1980
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979